Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cardiovascular Diabetology 20 (2021). 219.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2021
- Urheber
-
Pietschner, R.
Kolwelter, J.
Bosch, A.
Striepe, K.
Jung, S.
Kannenkeril, D.
Ott, C.
Schiffer, M.
Achenbach, S.
Schmieder, R. E.
- DOI
-
10.1186/s12933-021-01410-7
- URN
-
urn:nbn:de:bvb:29-opus4-181195
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pietschner, R.
- Kolwelter, J.
- Bosch, A.
- Striepe, K.
- Jung, S.
- Kannenkeril, D.
- Ott, C.
- Schiffer, M.
- Achenbach, S.
- Schmieder, R. E.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2021
Ähnliche Objekte (12)
Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers
Ketone bodies: from enemy to friend and guardian angel
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Analysis of the effects of ketone bodies on cardiac endothelial cells
Ketone Bodies and Exercise Performance: The Next Magic Bullet or Merely Hype?
Empagliflozin reduces interleukin-6 levels in patients with heart failure
g. Ketone
Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
Air‐Stable Manganese NNS Pincer Complexes Enable Ketone Reduction at Room Temperature
Acute Biomechanical Effects of Empagliflozin on Living Isolated Human Heart Failure Myocardium
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure
Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers
Ketone bodies: from enemy to friend and guardian angel
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Analysis of the effects of ketone bodies on cardiac endothelial cells
Ketone Bodies and Exercise Performance: The Next Magic Bullet or Merely Hype?
Empagliflozin reduces interleukin-6 levels in patients with heart failure
g. Ketone
Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
Air‐Stable Manganese NNS Pincer Complexes Enable Ketone Reduction at Room Temperature
Acute Biomechanical Effects of Empagliflozin on Living Isolated Human Heart Failure Myocardium
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure
Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers
Ketone bodies: from enemy to friend and guardian angel
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Analysis of the effects of ketone bodies on cardiac endothelial cells
Ketone Bodies and Exercise Performance: The Next Magic Bullet or Merely Hype?
Empagliflozin reduces interleukin-6 levels in patients with heart failure
g. Ketone
Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance
Air‐Stable Manganese NNS Pincer Complexes Enable Ketone Reduction at Room Temperature
Acute Biomechanical Effects of Empagliflozin on Living Isolated Human Heart Failure Myocardium